HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury.

Abstract
Spinal cord injury (SCI) in mammals has a poor outcome because of a lack of regeneration. Alteration of the local environment after injury may induce regeneration. However, the passage of blood-borne or exogenous neurotrophic substances through the blood-brain barrier (BBB) is not well characterized in either normal or injured states. We investigated the permeability of the BBB in normal and injured states to two markers of permeability (albumin and sucrose), to a peptide (ebiratide), and to a cytokine [tumor necrosis factor-alpha(TNF)]. We found that in normal mice the cervical and lumbar areas of the spinal cord were more permeable than the thoracic area and the brain to all four substances. The penetration of the alpha-MSH/ACTH analogue ebiratide and of TNF, substances that have saturable transport systems across the BBB and may be involved in regenerative processes in the CNS, followed a regional pattern of differential permeability comparable to that of albumin and sucrose. Complete transection at the lumbar level induced a temporal change in the permeability of the BBB. The increased permeability, as measured by the radioactively labeled tracers albumin and sucrose, was most apparent in the lumbar region proximal to the transection. After SCI, the permeability to ebiratide remained unchanged, suggesting that disruption of the BBB did not affect the transport system for ebiratide. By contrast, the increase of permeability to TNF exceeded that detected by the markers albumin and sucrose. This enhanced permeability was inhibited by excess unlabeled TNF in the blood, showing saturability. This suggests that the transport system for TNF may be activated in SCI.
AuthorsW Pan, W A Banks, A J Kastin
JournalExperimental neurology (Exp Neurol) Vol. 146 Issue 2 Pg. 367-73 (Aug 1997) ISSN: 0014-4886 [Print] United States
PMID9270046 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Peptide Fragments
  • Tumor Necrosis Factor-alpha
  • Adrenocorticotropic Hormone
  • ebiratide
Topics
  • Acute Disease
  • Adrenocorticotropic Hormone (analogs & derivatives, pharmacokinetics)
  • Animals
  • Biological Transport
  • Blood-Brain Barrier (drug effects)
  • Capillary Permeability (drug effects)
  • Male
  • Mice
  • Mice, Inbred ICR
  • Peptide Fragments (pharmacokinetics)
  • Reference Values
  • Spinal Cord Injuries (metabolism)
  • Tumor Necrosis Factor-alpha (pharmacokinetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: